688278 Xiamen Amoytop Biotech
- 50.09
- +0.99+2.02%
Xiamen Amoytop Biotech News
Xiamen Amoytop Biotech: Progress Announcement on Signing Exclusive License Agreement
Xiamen Amoytop Biotech: Voluntary disclosure notice on the proposed inclusion of additional indications for Pegobin in the priority review process
Xiamen Amoytop Biotech: 2023 Annual General Meeting of Shareholders Legal Opinions
Xiamen Amoytop Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Tebao Biotech: 2023 Annual General Meeting of Shareholders Meeting Information
Tebao Biotech: Notice on holding the 2023 Annual General Meeting of Shareholders
Tebao Biotech: Implementation Rules of the Board of Directors Remuneration and Assessment Committee (Revised in March 2024)
Tebao Biotech: Executive Rules of the Board Strategy Committee (revised in March 2024)
Tebao Biotech: Rules of Procedure for the Board of Directors (Revised in March 2024)
Tebao Biotech: Announcement on the revision of the “Articles of Association” and some governance systems
Tebao Biotech: Articles of Association (revised in March 2024)
Tebao Biotech: 2023 Internal Control Evaluation Report
Tebao Biotech: Report on the Audit Committee's performance of supervisory duties on accounting firms
Tebao Biotech: Report on the performance of the Audit Committee of the Board of Directors in 2023
Tebao Biotech: 2024 “Improve Quality, Increase Efficiency, and Reward” Special Action Plan
Tebao Biotech: Announcement on the Use of Some Idle Own Funds for Cash Management
Tebao Biotech: Implementation Rules for Audit Committee of the Board of Directors (revised in March 2024)
Tebao Biotech: Implementation Rules for the Nomination Committee of the Board of Directors (Revised in March 2024)
Tebao Bio: About Pegbin? Announcement on acceptance of marketing license applications for additional indications
Tebao Biotech: Announcement on the actual controller and those acting in concert voluntarily promise not to reduce the company\'s shares and the company\'s action plan to “improve quality, increase efficiency and increase return”
Analysis
Price Target
No Data
